FDA Submits Proposed Information Collection for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its ongoing efforts to comply with the requirements of the Federal Register notice (83 FR 51367, October 18, 2018), and to request public comment on the proposed information collection, specifically the 513(g) request for information.